Literature DB >> 15968767

[Devic's optic neuromyelitis and pulmonary tuberculosis].

H El Otmani1, M A Rafai, F Moutaouakil, B El Moutawakkil, I Gam, A El Meziane, I Slassi.   

Abstract

INTRODUCTION: Optic neuromyelitis or Devic's syndrome is a very rare disease affecting the optic tracts and the spinal cord. Its association with evolving pulmonary tuberculosis has been noted in a handful of case reports. CASE REPORT: The authors reportthe case of a 40 year old patient with evolving pulmonary tuberculosis who experienced bilateral blindness followed by paraplegia and sphincter disturbance. Clinical examination and investigations excluded direct tuberculous involvement of the nervous system or a reaction to antituberculous therapy and Devic's syndrome was diagnosed, based on Wingerchurk's criteria. Following treatment with corticosteroids and antituberculous chemotherapy, the patient recovered normal mobility and sphincter control but remained completely blind.
CONCLUSIONS: Throughout this case report, the authors emphasise the rarity of this association and discuss the pathophysiological mechanism, which appears to be an immune dysfunction triggered by mycobacterial infection.

Entities:  

Mesh:

Year:  2005        PMID: 15968767     DOI: 10.1016/s0761-8425(05)85445-2

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  3 in total

1.  Longitudinally extensive transverse myelitis with pulmonary tuberculosis: Two case reports.

Authors:  Yu Zhang; Mingqin Zhu; Lifang Wang; Miao Shi; Hui Deng
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

Review 2.  Neuromyelitis optica pathogenesis and aquaporin 4.

Authors:  David J Graber; Michael Levy; Douglas Kerr; William F Wade
Journal:  J Neuroinflammation       Date:  2008-05-29       Impact factor: 8.322

3.  Association between neuromyelitis optica and tuberculosis in a Chinese population.

Authors:  Rui Li; Xiaonan Zhong; Wei Qiu; Aimin Wu; Yongqiang Dai; Zhengqi Lu; Xueqiang Hu
Journal:  BMC Neurol       Date:  2014-02-20       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.